
SHINGRIX contains the active recombinant varicella zoster virus surface glycoprotein E antigen and is supplied as a lyophilized powder that needs reconstitution with an AS01 adjuvant suspension. It is an injectable vaccine designed for intramuscular use and is provided in a liquid form after reconstitution. Key inactive ingredients include sucrose as a stabilizer, sodium chloride, and polysorbate 80. SHINGRIX is intended to stimulate an immune response to prevent shingles.